Life Sciences
-
{
- All
- News
- Videos
-
CSIR-UGC National Eligibility Test December 2026: Biotechnology Exam Merged With Life Sciences
- Thursday October 8, 2026
- Education | Edited by Aayesha Sharma
CSIR-UGC NET December 2026: DBT-BET has been merged with Life Sciences. Check the new Life Sciences & Biotechnology discipline and details of the revised syllabus.
-
www.ndtv.com/education
-
Anthropic Unveils 'Claude Science' AI platform For Scientific Research
- Wednesday July 1, 2026
- Artificial Intelligence | Reuters
Anthropic is also launching its own pre-clinical drug programmes, focused on neglected diseases.
-
www.ndtv.com
-
BHU Opens Admissions For MSc In Life Sciences; Apply By July 10
- Sunday June 28, 2026
- Education | Edited by Priyanka Negi
BHU's DBT-Interdisciplinary School launches a new research-focused M.Sc Life Sciences program starting 2026-27 with a multidisciplinary curriculum.
-
www.ndtv.com/education
-
Laurus Labs, Biocon, Rubicon Lead Motilal Oswal’s Top Picks As Q3 Healthcare Outlook Brightens — Check Details
- Monday January 5, 2026
- Author: Motilal Oswal Financial Services
Q3 Healthcare Results Preview: Motilal Oswal sees strong Q3 for Laurus Labs, Biocon; hospitals to drive sector momentum
-
www.ndtvprofit.com
-
US Biosecure Act: Sai Life Sciences Plans Capacity Expansion By FY27 Amid China-Plus-One Shift
- Monday December 15, 2025
- Author: Heena Ojha
The act which mainly aims to safeguard American biotech and health data from foreign threats, particularly those posed by Chinese companies will likely benefit Indian companies.
-
www.ndtvprofit.com
-
Buy, Sell Or Hold: Whirlpool, Sai Life Sciences, HDFC Life, Apollo Micro Systems, Union Bank — Ask Profit
- Tuesday December 2, 2025
- Author: Ann Jacob
Analysts answered an array of investor queries on various stocks, including Yes Bank. Here are the key buy, sell and hold recommendations.
-
www.ndtvprofit.com
-
Pharma Sector Sees Modest Growth Amid US Headwinds; Sun Pharma, Cipla Among ICICI Securities' Top Picks
- Thursday October 9, 2025
- Author: ICICI Securities
Pharma Q2 Resulte Preview: ICICI Securities remains cautious on the near-term outlook for pharma sector citing US tariffs uncertainty, NLEM price revision in 2026.
-
www.ndtvprofit.com
-
Sai Life Sciences Bulk Deal: TPG Exits Via Rs 2,675-Crore Sale; Societe Generale, Goldman Sachs Acquire
- Tuesday August 26, 2025
- Author: Khushi Maheshwari
IIFL Capital Services Ltd., Kotak Securities Ltd. and Jefferies India Pvt. were the bookrunners for the deal.
-
www.ndtvprofit.com
-
Sai Life Sciences Block Deal: TPG Likely To Exit Via Rs 2,640-Crore Stake Sale
- Monday August 25, 2025
- Author: Pratiksha Thayil
Sai Life Sciences is an innovator-focused contract research, development, and manufacturing organisation based in Hyderabad.
-
www.ndtvprofit.com
-
Sai Life Sciences Block Deal: Domestic Mutual Funds Buy In Led By Nippon India
- Friday June 20, 2025
- Author: Divya Prata
US private equity firm TPG's affiliate TPG Asia VII SF Pte, a prominent public shareholder of Sai Life Sciences, offloaded 2.08 crore shares, accounting for 10% of the company's equity.
-
www.ndtvprofit.com
-
Sai Life Sciences Block Deal: TPG Offers To Sell 6% Stake For Rs 888 Crore
- Thursday June 19, 2025
- Author: Prajwal Jayaraj
The move comes after 48% equity of Sai Life Sciences became eligible for trade on Monday as the six-month lock-in period ends for shareholders.
-
www.ndtvprofit.com
-
Pharma Q4 Results Review — India Traction Healthy; Post gRevlimid Uncertainty Looms, Says ICICI Securities
- Tuesday June 10, 2025
- Author: ICICI Securities
Pharma Q4 Results Review: Sun Pharma, Cipla, Torrent, Piramal Pharma, Akums and Abbott India among ICICI Securities top picks
-
www.ndtvprofit.com
-
Sai Lifesciences Gets Target Price Hike From Morgan Stanley As Growth Outpaces Industry
- Thursday May 15, 2025
- Author: Ananya Chaudhuri
Sai Lifesciences was able to grow its contract research business 26% year-on-year in financial year 2025 even as funding in the biotechnology environment softened.
-
www.ndtvprofit.com
-
CSIR-UGC National Eligibility Test December 2026: Biotechnology Exam Merged With Life Sciences
- Thursday October 8, 2026
- Education | Edited by Aayesha Sharma
CSIR-UGC NET December 2026: DBT-BET has been merged with Life Sciences. Check the new Life Sciences & Biotechnology discipline and details of the revised syllabus.
-
www.ndtv.com/education
-
Anthropic Unveils 'Claude Science' AI platform For Scientific Research
- Wednesday July 1, 2026
- Artificial Intelligence | Reuters
Anthropic is also launching its own pre-clinical drug programmes, focused on neglected diseases.
-
www.ndtv.com
-
BHU Opens Admissions For MSc In Life Sciences; Apply By July 10
- Sunday June 28, 2026
- Education | Edited by Priyanka Negi
BHU's DBT-Interdisciplinary School launches a new research-focused M.Sc Life Sciences program starting 2026-27 with a multidisciplinary curriculum.
-
www.ndtv.com/education
-
Laurus Labs, Biocon, Rubicon Lead Motilal Oswal’s Top Picks As Q3 Healthcare Outlook Brightens — Check Details
- Monday January 5, 2026
- Author: Motilal Oswal Financial Services
Q3 Healthcare Results Preview: Motilal Oswal sees strong Q3 for Laurus Labs, Biocon; hospitals to drive sector momentum
-
www.ndtvprofit.com
-
US Biosecure Act: Sai Life Sciences Plans Capacity Expansion By FY27 Amid China-Plus-One Shift
- Monday December 15, 2025
- Author: Heena Ojha
The act which mainly aims to safeguard American biotech and health data from foreign threats, particularly those posed by Chinese companies will likely benefit Indian companies.
-
www.ndtvprofit.com
-
Buy, Sell Or Hold: Whirlpool, Sai Life Sciences, HDFC Life, Apollo Micro Systems, Union Bank — Ask Profit
- Tuesday December 2, 2025
- Author: Ann Jacob
Analysts answered an array of investor queries on various stocks, including Yes Bank. Here are the key buy, sell and hold recommendations.
-
www.ndtvprofit.com
-
Pharma Sector Sees Modest Growth Amid US Headwinds; Sun Pharma, Cipla Among ICICI Securities' Top Picks
- Thursday October 9, 2025
- Author: ICICI Securities
Pharma Q2 Resulte Preview: ICICI Securities remains cautious on the near-term outlook for pharma sector citing US tariffs uncertainty, NLEM price revision in 2026.
-
www.ndtvprofit.com
-
Sai Life Sciences Bulk Deal: TPG Exits Via Rs 2,675-Crore Sale; Societe Generale, Goldman Sachs Acquire
- Tuesday August 26, 2025
- Author: Khushi Maheshwari
IIFL Capital Services Ltd., Kotak Securities Ltd. and Jefferies India Pvt. were the bookrunners for the deal.
-
www.ndtvprofit.com
-
Sai Life Sciences Block Deal: TPG Likely To Exit Via Rs 2,640-Crore Stake Sale
- Monday August 25, 2025
- Author: Pratiksha Thayil
Sai Life Sciences is an innovator-focused contract research, development, and manufacturing organisation based in Hyderabad.
-
www.ndtvprofit.com
-
Sai Life Sciences Block Deal: Domestic Mutual Funds Buy In Led By Nippon India
- Friday June 20, 2025
- Author: Divya Prata
US private equity firm TPG's affiliate TPG Asia VII SF Pte, a prominent public shareholder of Sai Life Sciences, offloaded 2.08 crore shares, accounting for 10% of the company's equity.
-
www.ndtvprofit.com
-
Sai Life Sciences Block Deal: TPG Offers To Sell 6% Stake For Rs 888 Crore
- Thursday June 19, 2025
- Author: Prajwal Jayaraj
The move comes after 48% equity of Sai Life Sciences became eligible for trade on Monday as the six-month lock-in period ends for shareholders.
-
www.ndtvprofit.com
-
Pharma Q4 Results Review — India Traction Healthy; Post gRevlimid Uncertainty Looms, Says ICICI Securities
- Tuesday June 10, 2025
- Author: ICICI Securities
Pharma Q4 Results Review: Sun Pharma, Cipla, Torrent, Piramal Pharma, Akums and Abbott India among ICICI Securities top picks
-
www.ndtvprofit.com
-
Sai Lifesciences Gets Target Price Hike From Morgan Stanley As Growth Outpaces Industry
- Thursday May 15, 2025
- Author: Ananya Chaudhuri
Sai Lifesciences was able to grow its contract research business 26% year-on-year in financial year 2025 even as funding in the biotechnology environment softened.
-
www.ndtvprofit.com